DIFFUSE LARGE B-CELL LYMPHOMA STAGE III

This adverse event was reported 79 times

DIFFUSE LARGE B-CELL LYMPHOMA STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEXTROSE AND POTASSIUM CHLORIDE 1 0.0588
1 SENNOSIDES, STIMULANT LAXATIVE 1 0.0139
2 NEOSTIGMINE METHYLSULFATE 1 0.0023
3 LENIOLISIB 1 0.0011
4 BETAMETHASONE VALERATE FOAM 3 0.0007
5 NALDEMEDINE 1 0.0006
6 MESNA INJECTION 4 0.0005
7 MESNA 4 0.0005
8 RASBURICASE 1 0.0004
9 PILOCARPINE HYDROCHLORIDE 1 0.0004
See all drugs enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA STAGE III

These drug classes are most commonly taken by patients reporting DIFFUSE LARGE B-CELL LYMPHOMA STAGE III:

# Drug class Count
See all common drug classes associated with DIFFUSE LARGE B-CELL LYMPHOMA STAGE III

DIFFUSE LARGE B-CELL LYMPHOMA STAGE III is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
See all drug classes enriched for association with DIFFUSE LARGE B-CELL LYMPHOMA STAGE III